Do Analysts Agree Monday on Sana Biotechnology Inc (SANA) Stock’s Target Price?

Wall Street is positive on Sana Biotechnology Inc (SANA). On average, analysts give SANA a Buy rating. The average price target is $10, which means analysts expect the stock to add by 82.82% over the next twelve months.

That average ranking earns SANA an Analyst Rating of 36, which is better than 36% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating SANA a Buy today. Find out what this means to you and get the rest of the rankings on SANA!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.

InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What’s Happening With Sana Biotechnology Inc Stock Today?

Sana Biotechnology Inc (SANA) stock has gained 5.39% while the S&P 500 has fallen -0.21% as of 2:01 PM on Monday, Apr 17. SANA is higher by $0.28 from the previous closing price of $5.19 on volume of 1,496,352 shares. Over the past year the S&P 500 is lower by -5.99% while SANA has fallen -26.97%. SANA lost -$1.43 per share the over the last 12 months.

Click Here to get the full Stock Report for Sana Biotechnology Inc stock.